Biology Reference
In-Depth Information
Coatney, G.R., 1963. Pitfalls in a discovery: the chronicle of chloroquine. Am. J. Trop. Med.
Hyg. 12, 121-128.
Coatney, G.R., 1971. Primate Malarias. US Government Printing Office, Washington, DC.
Collins, W.E., Schwartz, I.K., Skinner, J.C., Morris, C., Filipski, V.K., 1992. The susceptibil-
ity of the Indonesian I/CDC strain of
Plasmodium vivax
to chloroquine. J. Parasitol.
78, 344-349.
Collins, W.E., Richardson, B.B., Morris, C.L., Sullivan, J.S., Galland, G.G., 1998. Salvador II
strain of
Plasmodium vivax
in Aotus monkeys and mosquitoes for transmission-blocking
vaccine trials. Am. J. Trop. Med. Hyg. 59, 29-34.
Collins, W.E., Sullivan, J.S., Fryauff, D.J., Kendall, J., Jennings, V., et al., 2000. Adaptation of a
chloroquine-resistant strain of
Plasmodium vivax
from Indonesia to New World monkeys.
Am. J. Trop. Med. Hyg. 62, 491-495.
Collins, W.E., Sullivan, J.S., Galland, G.G., Williams, A., Nace, D., et al., 2005. Observations
on the Vietnam Palo Alto strain of
Plasmodium vivax
in two species of Aotus monkeys.
J. Parasitol. 91, 461-463.
Comfort, N., 2009. The prisoner as model organism: malaria research at Stateville Peniten-
tiary. Stud. Hist. Philos. Biol. Biomed. Sci. 40, 190-203.
Congpuong, K., Na-Bangchang, K., Thimasarn, K., Tasanor, U., Wernsdorfer, W.H., 2002.
Sensitivity of
Plasmodium vivax
to chloroquine in Sa Kaeo Province, Thailand. Acta Trop.
83, 117-121.
Cooper,W.C., Myatt, A.V., Hernandez,T., Jeffery, G.M., Coatney, G.R., 1953. Studies in human
malaria. XXXI. Comparison of primaquine, isopentaquine, SN-3883, and pamaquine as
curative agents against Chesson strain vivax malaria. Am. J. Trop. Med. Hyg. 2, 949-957.
Cooper, R.D., Milhous, W.K., Rieckmann, K.H., 1994. The efficacy of WR238605 against
the blood stages of a chloroquine resistant strain of
Plasmodium vivax
. Trans. R. Soc. Trop.
Med. Hyg. 88, 691-692.
Craige Jr., B., Alving, A.S., et al., 1947a. The Chesson strain of
Plasmodium vivax
malaria;
relationship between prepatent period, latent period and relapse rate. J. Infect. Dis.
80, 228-236.
Craige, B.J., Jones, R.J., Whorton, C.M., Pullman, T.N., Alving, A.S., et al., 1947b. Clinical
standardization of pamaquine (plasmochin) in mosquito-induced vivax malaria, Chesson
strain. Am. J. Trop. Med. Hyg. 27, 309-315.
Curlin, M.E., Barat, L.M., Walsh, D.K., Granger, D.L., 1999. Noncardiogenic pulmonary
edema during vivax malaria. Clin. Infect. Dis. 28, 1166-1167.
Darlow, B.,Vrbova, H., Gibney, S., Jolley, D., Stace, J., et al., 1982. Sulfadoxine-pyrimethamine
for the treatment of acute malaria in children of Papua New Guinea. II.
Plasmodium
vivax
. Am. J. Trop. Med. Hyg. 31, 10-13.
Davidson Jr., D.E., Ager, A.L., Brown, J.L., Chapple, F.E., Whitmire, R.E., et al., 1981. New
tissue schizontocidal antimalarial drugs. Bull. World Health Organ. 59, 463-479.
de Santana Filho, F.S., Arcanjo, A.R., Chehuan, Y.M., Costa, M.R., Martinez-Espinosa, F.E.,
et al., 2007. Chloroquine-resistant
Plasmodium vivax
, Brazilian Amazon. Emerg. Infect.
Dis. 13, 1125-1126.
Di Lorenzo, A., Marx, R.L., Alving, A.S., Jones Jr., R., 1953. Korean vivax malaria. IV. Curative
effect of 15 milligrams of primaquine daily for 7 days. Am. J. Trop. Med. Hyg. 2, 983-984.
Douglas, N.M., Anstey, N.M., Angus, B.J., Nosten, F., Price, R.N., 2010. Artemisinin combi-
nation therapy for vivax malaria. Lancet Infect. Dis. 10, 405-416.
Douglas, N.M., Nosten, F., Ashley, E.A., Phaiphun, L., van Vugt, M., et al., 2011.
Plasmodium
vivax
recurrence following falciparum and mixed species malaria: risk factors and effect
of antimalarial kinetics. Clin. Infect. Dis. 52, 612-620.
Dow, G.S., Gettayacamin, M., Hansukjariya, P., Imerbsin, R., Komcharoen, S., et al., 2011.
Radical curative efficacy of tafenoquine combination regimens in
Plasmodium cynomolgi
-
infected Rhesus monkeys (Macaca mulatta). Malar. J. 10, 212.
